February 10, 2023 – Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results